Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis.

Miyabe C, Miyabe Y, Nagai J, Miura NN, Ohno N, Chun J, Tsuboi R, Ueda H, Miyasaka M, Miyasaka N, Nanki T.

Arthritis Res Ther. 2019 Aug 20;21(1):191. doi: 10.1186/s13075-019-1973-0.

2.

Dectin-2-induced CCL2 production in tissue-resident macrophages ignites cardiac arteritis.

Miyabe C, Miyabe Y, Bricio-Moreno L, Lian J, Rahimi RA, Miura NN, Ohno N, Iwakura Y, Kawakami T, Luster AD.

J Clin Invest. 2019 Jun 6;130. pii: 123778. doi: 10.1172/JCI123778.

3.

Atypical complement receptor C5aR2 transports C5a to initiate neutrophil adhesion and inflammation.

Miyabe Y, Miyabe C, Mani V, Mempel TR, Luster AD.

Sci Immunol. 2019 May 10;4(35). pii: eaav5951. doi: 10.1126/sciimmunol.aav5951.

PMID:
31076525
4.

Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment.

Alapafuja SO, Malamas MS, Shukla V, Zvonok A, Miller S, Daily L, Rajarshi G, Miyabe CY, Chandrashekhar H, Wood J, Tyukhtenko S, Straiker A, Makriyannis A.

Bioorg Med Chem. 2019 Jan 1;27(1):55-64. doi: 10.1016/j.bmc.2018.11.003. Epub 2018 Nov 3.

PMID:
30446439
5.

Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis.

Angelini A, Miyabe Y, Newsted D, Kwan BH, Miyabe C, Kelly RL, Jamy MN, Luster AD, Wittrup KD.

Nat Commun. 2018 Apr 13;9(1):1461. doi: 10.1038/s41467-018-03687-x.

6.

Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients.

Prieto-González S, Terrades-García N, Corbera-Bellalta M, Planas-Rigol E, Miyabe C, Alba MA, Ponce A, Tavera-Bahillo I, Murgia G, Espígol-Frigolé G, Marco-Hernández J, Hernández-Rodríguez J, García-Martínez A, Unizony SH, Cid MC.

RMD Open. 2017 Dec 22;3(2):e000570. doi: 10.1136/rmdopen-2017-000570. eCollection 2017.

7.

LTB4 and BLT1 in inflammatory arthritis.

Miyabe Y, Miyabe C, Luster AD.

Semin Immunol. 2017 Oct;33:52-57. doi: 10.1016/j.smim.2017.09.009. Review.

PMID:
29042029
8.

Complement C5a Receptor is the Key Initiator of Neutrophil Adhesion Igniting Immune Complex-induced Arthritis.

Miyabe Y, Miyabe C, Murooka TT, Kim EY, Newton GA, Kim ND, Haribabu B, Luscinskas FW, Mempel TR, Luster AD.

Sci Immunol. 2017 Jan;2(7). pii: eaaj2195. doi: 10.1126/sciimmunol.aaj2195. Epub 2017 Jan 20.

9.

A sphingosine 1-phosphate receptor agonist ameliorates animal model of vasculitis.

Miyabe C, Miyabe Y, Komiya T, Shioya H, Miura NN, Takahashi K, Ohno N, Tsuboi R, Luster AD, Kawai S, Miyasaka N, Nanki T.

Inflamm Res. 2017 Apr;66(4):335-340. doi: 10.1007/s00011-016-1018-y. Epub 2016 Dec 10.

PMID:
27942751
10.

An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy.

Miyabe C, Miyabe Y, Strle K, Kim ND, Stone JH, Luster AD, Unizony S.

Ann Rheum Dis. 2017 May;76(5):898-905. doi: 10.1136/annrheumdis-2016-210070. Epub 2016 Dec 7.

11.

Studying Neutrophil Migration In Vivo Using Adoptive Cell Transfer.

Miyabe Y, Kim ND, Miyabe C, Luster AD.

Methods Mol Biol. 2016;1407:179-94. doi: 10.1007/978-1-4939-3480-5_14.

PMID:
27271903
12.

Studying Chemokine Control of Neutrophil Migration In Vivo in a Murine Model of Inflammatory Arthritis.

Miyabe Y, Kim ND, Miyabe C, Luster AD.

Methods Enzymol. 2016;570:207-31. doi: 10.1016/bs.mie.2015.11.002. Epub 2016 Jan 6.

PMID:
26921948
13.

Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade.

Miyabe Y, Miyabe C, Iwai Y, Yokoyama W, Sekine C, Sugimoto K, Harigai M, Miyasaka M, Miyasaka N, Nanki T.

Arthritis Res Ther. 2014 Oct 2;16(5):461. doi: 10.1186/s13075-014-0461-9.

14.

Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice.

Yokoyama W, Kohsaka H, Kaneko K, Walters M, Takayasu A, Fukuda S, Miyabe C, Miyabe Y, Love PE, Nakamoto N, Kanai T, Watanabe-Imai K, Charvat TT, Penfold ME, Jaen J, Schall TJ, Harigai M, Miyasaka N, Nanki T.

Arthritis Res Ther. 2014 Sep 24;16(5):445. doi: 10.1186/s13075-014-0445-9.

15.

Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis.

Fukuda S, Kohsaka H, Takayasu A, Yokoyama W, Miyabe C, Miyabe Y, Harigai M, Miyasaka N, Nanki T.

BMC Musculoskelet Disord. 2014 Aug 12;15:275. doi: 10.1186/1471-2474-15-275.

16.

Could retinoids be a potential treatment for rheumatic diseases?

Miyabe Y, Miyabe C, Nanki T.

Rheumatol Int. 2015 Jan;35(1):35-41. doi: 10.1007/s00296-014-3067-2. Epub 2014 Jun 18. Review.

PMID:
24939557
17.

An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II-dependent hypertension.

Ulu A, Stephen Lee KS, Miyabe C, Yang J, Hammock BG, Dong H, Hammock BD.

J Cardiovasc Pharmacol. 2014 Jul;64(1):87-99. doi: 10.1097/FJC.0000000000000094.

18.

Tiny disseminated angiomas from childhood.

Miyabe C, Okubo Y, Maeda T, Tsuboi R, Mitsuhashi Y.

Eur J Dermatol. 2013 Sep-Oct;23(5):718-9. doi: 10.1684/ejd.2013.2119. No abstract available.

PMID:
24126209
19.

CCL18 activates fibroblast-like synoviocytes in patients with rheumatoid arthritis.

Takayasu A, Miyabe Y, Yokoyama W, Kaneko K, Fukuda S, Miyasaka N, Miyabe C, Kubota T, Nanki T.

J Rheumatol. 2013 Jun;40(6):1026-8. doi: 10.3899/jrheum.121412. No abstract available.

PMID:
23728190
20.

Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.

Ulu A, Harris TR, Morisseau C, Miyabe C, Inoue H, Schuster G, Dong H, Iosif AM, Liu JY, Weiss RH, Chiamvimonvat N, Imig JD, Hammock BD.

J Cardiovasc Pharmacol. 2013 Sep;62(3):285-97. doi: 10.1097/FJC.0b013e318298e460.

21.

Necessity of lysophosphatidic acid receptor 1 for development of arthritis.

Miyabe Y, Miyabe C, Iwai Y, Takayasu A, Fukuda S, Yokoyama W, Nagai J, Jona M, Tokuhara Y, Ohkawa R, Albers HM, Ovaa H, Aoki J, Chun J, Yatomi Y, Ueda H, Miyasaka M, Miyasaka N, Nanki T.

Arthritis Rheum. 2013 Aug;65(8):2037-47. doi: 10.1002/art.37991.

22.

Am80, a retinoic acid receptor agonist, ameliorates murine vasculitis through the suppression of neutrophil migration and activation.

Miyabe C, Miyabe Y, Miura NN, Takahashi K, Terashima Y, Toda E, Honda F, Morio T, Yamagata N, Ohno N, Shudo K, Suzuki J, Isobe M, Matsushima K, Tsuboi R, Miyasaka N, Nanki T.

Arthritis Rheum. 2013 Feb;65(2):503-12. doi: 10.1002/art.37784.

23.

Nephrogenic systemic fibrosis: a case report and review on Japanese patients.

Matsumoto Y, Mitsuhashi Y, Monma F, Kawaguchi M, Suzuki T, Miyabe C, Igarashi A, Tsuboi R.

J Dermatol. 2012 May;39(5):449-53. doi: 10.1111/j.1346-8138.2011.01407.x. Epub 2011 Oct 31. Review.

PMID:
22035371
24.

Novel mutation in the ATP2A2 gene in a Japanese Darier's disease patient with extremely hyperkeratotic lesions.

Miyabe C, Mitsuhashi Y, Saito M, Tsuboi R.

J Dermatol. 2012 Apr;39(4):401-3. doi: 10.1111/j.1346-8138.2011.01288.x. Epub 2011 Oct 31. No abstract available.

PMID:
22035154
25.

Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis.

Kaneko K, Miyabe Y, Takayasu A, Fukuda S, Miyabe C, Ebisawa M, Yokoyama W, Watanabe K, Imai T, Muramoto K, Terashima Y, Sugihara T, Matsushima K, Miyasaka N, Nanki T.

Arthritis Res Ther. 2011;13(5):R158. doi: 10.1186/ar3475. Epub 2011 Sep 29.

26.

Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys.

Ulu A, Appt S, Morisseau C, Hwang SH, Jones PD, Rose TE, Dong H, Lango J, Yang J, Tsai HJ, Miyabe C, Fortenbach C, Adams MR, Hammock BD.

Br J Pharmacol. 2012 Mar;165(5):1401-12. doi: 10.1111/j.1476-5381.2011.01641.x.

Supplemental Content

Loading ...
Support Center